Interestingly, this reinforces the value of using RANKL inhibition to treat osteosarcoma, but also sustains the role of osteoclasts in the metastasis process by bolstering tumor cell escape (Figure 6), as previously described [41]. The gene discussed is TNFSF11; the disease is osteosarcoma.